1 TSX Healthcare Stock Turned $10,000 Into $50,000 Since its IPO in December 2017

Here’s why Viemed stock remains a top bet for long-term investors.

| More on:
healthcare pharma

Image source: Getty Images

Viemed Healthcare (TSX:VMD)(NASDAQ:VMD), is a home medical equipment supplier that specializes in providing respiratory services to patients. It also provides equipment for neuromuscular diseases, home sleep testing kits, treatment for sleep apnea as well as chronic obstructive pulmonary disease (COPD). The company currently operates in 24 states in the United States. Statistically, around 25 million Americans are reported to be suffering from COPD, which happens to be the third-largest killer after cancer and congestive heart failure, and Viemed operates in this space.

Massive returns

Viemed Healthcare is one of the many healthcare stocks that saw a major surge during the COVID-19 pandemic. Its shares closed at $7.41 on April 6, 2020, and are currently trading at $12.96, gaining almost 75% in the last year.

However, it would be unfair to say that the pandemic is responsible for Viemed’s great returns. The stock has been a star performer for some time now. The stock closed at $2.40 after it went public and has delivered returns of almost 440% in a little over three years. A $10,000 investment in Viemed stock soon after its IPO would be worth $52,000 today.

Viemed recently reported record numbers for its fourth quarter of 2020. Net revenue for the company’s core business in Q4 rose 22% to $26.1 million. Its adjusted EBITDA for Q4 also jumped by a massive 70% to $9.5 million compared to 2019.

Net revenue for the whole of 2020 was $131.3 million. Revenue from COVID-19 related activities at $34.4 million was a major contributor to the company’s top and bottom lines. Net income for 2020 came in at $31.5 million compared to $8.5 million in 2019. Viemed Healthcare had $31 million in cash at the end of 2020 and long-term debt was $6.6 million.

What’s next for Viemed investors?

The company says it has carried this momentum into 2021. Total revenue for the first quarter of 2021 is estimated to be approximately $27.8 million to $29.8 million.

Viemed is looking at opportunities in areas related to the COVID-19 pandemic. According to their CEO Casey Hoyt, “The pandemic has posed more tailwinds than headwinds for us, and that has resulted in a record year for Viemed.”

Along with its core rental business, the company intends on growth via strategic partnerships, accretive acquisition opportunities as well as organic growth, such as supplying source equipment and PPE kits which it hopes will help contribute to Viemed’s expansion in 2021.

Viemed acquired remote patient monitor VeruStat in December, and the numbers from this acquisition should start clocking in in 2021. Viemed says VeruStat’s internally developed PEP will result in better patient compliance as well as help to optimize labour and workflow, allowing the company to add new adjacencies to its core respiratory business. Through this investment, the company has ventured into the healthcare technology sector and will get a new revenue source added to its physician source.

Viemed is also fellow Fool Robin Brown’s pick in this month’s Top TSX Stocks Picks for April 2021. Keeping the company’s steady growth into consideration, an investment in Viemed Health Care might be a good decision, as it readies itself to report numbers for Q1 of 2021.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Viemed Healthcare Inc. Aditya Raghunath has no position in any of the stocks mentioned.

More on Coronavirus

Dad and son having fun outdoor. Healthy living concept
Dividend Stocks

1 Growth Stock Down 15.8% to Buy Right Now

A growth stock is well-positioned to resume its upward momentum in 2024 following its strong financial results and business momentum.

Read more »

Double exposure of a businessman and stairs - Business Success Concept
Stocks for Beginners

3 Things About Couche-Tard Stock Every Smart Investor Knows

Couche-tard stock (TSX:ATD) may be up 30% this year, but look at the leadership and history of the stock to…

Read more »

Plane on runway, aircraft
Coronavirus

Can Air Canada Double in 5 Years? Here’s What it Would Take

Air Canada (TSX:AC) stock has gone nowhere since 2020. Can this change?

Read more »

Senior housing
Stocks for Beginners

Home Improvement Stocks Are Set to Fall (When They Do, Buy These Like Crazy!)

Home improvement stocks are due to drop further in the coming months. But with solid underpinnings for the sector, it…

Read more »

An airplane on a runway
Coronavirus

Forget Boeing: Buy This Magnificent Airline Stock Instead

Boeing (NYSE:BA) stock is looking risky right now, but Air Canada (TSX:AC) stock? Much less so.

Read more »

Man considering whether to sell or buy
Stocks for Beginners

Goeasy Stock: Buy, Sell, or Hold?

When it comes to smart buys, goeasy stock (TSX:GSY) is up there as one of the smartest money can buy.…

Read more »

Woman has an idea
Stocks for Beginners

Here’s Why Magna International Is a No-Brainer Value Stock

Magna stock (TSX:MG) has been climbing back once more, but still offers huge value for long-term minded investors.

Read more »

Aircraft wing plane
Coronavirus

1 TSX Stock Down 60% That Could Bounce Back Stronger

Air Canada (TSX:AC) stock got severely beaten down in the March 2020 COVID crash. Here's why it's probably not going…

Read more »